My Gene Counsel
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • BIOPHARMA, CLINICAL TRIALS & PAYERS
  • Solutions
    • My Gene Screen
    • Living Lab Reports
    • Genetic Alerts
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
My Gene Counsel Quoted in Washington Post and Kaiser Health News

My Gene Counsel Quoted in Washington Post and Kaiser Health News

by Danielle Bonadies | Feb 9, 2021 | News

As seen on The Washington Post and Kaiser Health News By Christina Bennett When her gynecologist recommended genetic testing, Mai Tran was reluctant. “I didn’t really want to do it,” recalled Tran, who had just turned 21 and was living in New...
Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

by Danielle Bonadies | Jan 2, 2020 | News

In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...
Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

My Gene Counsel Weighs in on Large-Scale Multigene Panel Study of Hereditary Cancer Risk

by Danielle Bonadies | Sep 12, 2019 | News

Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk...
How Life Has Changed in the Genomics World Post Gene Patents

How Life Has Changed in the Genomics World Post Gene Patents

by Danielle Bonadies | Jun 13, 2017 | Genetic Journal

On June 13, 2013, in the case of the Association for Molecular Pathology v. Myriad Genetics, Inc., the Supreme Court of the United States ruled that human genes cannot be patented in the U.S. because DNA is a “product of nature.” The Court decided that...
Testing Negative and Living in the Gray Zone for Cancer Risk

Testing Negative and Living in the Gray Zone for Cancer Risk

by Danielle Bonadies | Feb 16, 2016 | Genetic Journal

This is Stacey’s story of searching for a genetic explanation for the prevalence of breast cancer in her family. Genetic Counseling Note: When a patient tests ‘negative’ for genetic mutations, part of the genetic counseling process is to...

Recent Posts

  • Genetic Testing Challenges in Precision Medicine: Lab Fails to Report NF2 Mosaic Variant
  • Career Compass: Tips and Tricks for Second Year Students and Recent Graduates with Christina Frater
  • Continuing Education Opportunities
  • ABGC Boards Resources
  • The Speed and Scope of Genetic Updates | My Gene Counsel

Archives

  • About Us
  • Media
  • Genetic Journal Blog
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • Biopharma, Clinical Trials & Payers
  • My Gene Screen
  • Living Lab Reports®
  • Genetic Alerts
  • Contact Us
  • FAQs
  • Career Resources

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©